Glucose-6-phosphate dehydrogenase and transketolase: Key factors in breast cancer progression and therapy.
Biomed Pharmacother
; 176: 116935, 2024 Jul.
Article
en En
| MEDLINE
| ID: mdl-38876050
ABSTRACT
Breast cancer is one of the most common malignant tumors in women and is a serious threat to women's health. The pentose phosphate pathway (PPP) is a mode of oxidative breakdown of glucose that can be divided into oxidative (oxPPP) and non-oxidative (non-oxPPP) stages and is necessary for cell and body survival. However, abnormal activation of PPP often leads to proliferation, migration, invasion, and chemotherapy resistance in breast cancer. Glucose-6-phosphate dehydrogenase (G6PD) is the rate-limiting enzyme in PPP oxidation. Nicotinamide adenine dinucleotide phosphate hydrogen (NADPH) produced by G6PD is the raw material for cholesterol and lipid synthesis and can resist the production of oxygen species (ROS) and reduce oxidative stress damage to tumor cells. Transketolase (TKT) is a key enzyme in non-oxPPP. Ribose 5-phosphate (R5P), produced by TKT, is a raw material for DNA and RNA synthesis, and is essential for tumor cell proliferation and DNA damage repair. In this review, we describe the role and specific mechanism of the PPP and the two most important enzymes of the PPP, G6PD and TKT, in the malignant progression of breast cancer, providing strategies for future clinical treatment of breast cancer and a theoretical basis for breast cancer research.
Palabras clave
Texto completo:
1
Base de datos:
MEDLINE
Asunto principal:
Vía de Pentosa Fosfato
/
Transcetolasa
/
Neoplasias de la Mama
/
Progresión de la Enfermedad
/
Glucosafosfato Deshidrogenasa
Límite:
Animals
/
Female
/
Humans
Idioma:
En
Revista:
Biomed Pharmacother
Año:
2024
Tipo del documento:
Article